Physician profile
Michael Ghaly
NPI 1942872510
$289.09
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.73 · 2023: $214 · 2024: $22.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $131.79 | 2023 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $39.08 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.86 | 2021-2023 | Jardiance |
| Abiomed | $22.50 | 2024 | Impella |
| Corcept Therapeutics | $20.70 | 2023 | Korlym |
| Insulet Corporation | $19.34 | 2023 | Omnipod |
| Abbvie INC. | $14.99 | 2023 | |
| Averitas Pharma INC. | $13.83 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ghaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.